🦷 Granular Cell Ameloblastoma (GCA)
📖 Definition
Granular Cell Ameloblastoma (GCA) is a rare histological variant of conventional ameloblastoma, a benign but locally aggressive odontogenic epithelial tumor, characterized by peripheral ameloblast-like cells and a central stellate-reticulum–like component.
In the granular variant, the central cells acquire abundant eosinophilic granular cytoplasm, due to the accumulation of lysosomes【WHO 2022】.
📊 Epidemiology
Ameloblastoma accounts for about 1% of all head and neck neoplasms.
The granular cell subtype represents approximately 3–5% of cases【PathologyOutlines】.
Most common in the mandible (87%), especially the posterior region.
Age range: adults in the 3rd to 5th decade, though it may occur across a broad age spectrum.
No significant sex predilection.
🧬 Etiology / Pathophysiology
Exact etiology remains unknown.
Molecular pathogenesis:
Alterations in the MAPK/ERK pathway are the most common.
BRAF p.V600E mutation is the most frequent, especially in mandibular tumors.
Less common mutations: RAS and FGFR2.
In the granular subtype, cytoplasmic granularity results from lysosomal accumulation in central cells, interpreted as a degenerative/metabolic process rather than an independent prognostic marker.
🤒 Clinical Manifestations
Slow-growing, painless swelling in the mandible or maxilla.
May cause:
Cortical bone expansion and perforation.
Tooth mobility or loss.
Local paresthesia in larger tumors.
If untreated, it may become large, leading to facial deformity and involvement of adjacent structures.
🧪 Laboratory Diagnosis
No specific serum biomarkers.
Histopathological evaluation is mandatory for diagnosis.
Molecular testing (e.g., BRAF status) may aid in prognostic stratification and targeted therapy selection.
🖼️ Imaging and Pathology Findings
Radiology
Multilocular radiolucency with “soap bubble” or “honeycomb” appearance, well-corticated margins.
CT (preferably contrast-enhanced): better defines size, content, cortical expansion, and perforation.
Associated with impacted teeth in up to 18% of cases.
Histopathology
Epithelial islands in fibrous stroma.
Peripheral cells: columnar/cuboidal, hyperchromatic nuclei, reverse polarity, subnuclear vacuolization.
Central cells: stellate-reticulum–like, but with abundant eosinophilic granular cytoplasm filled with lysosomes.
No significant atypia or mitotic activity.
May coexist with other histological patterns (follicular, plexiform, etc.).
🔍 Differential Diagnosis
Granular cell tumor (Abrikossoff’s tumor): soft tissue lesion, S100 , lacks ameloblastomatous architecture.
Oncocytic odontogenic tumor: granular cytoplasm, different growth pattern.
Other ameloblastoma subtypes (acanthomatous, follicular, plexiform, etc.).
Odontogenic carcinoma (rare, in atypical or aggressive cases).
📉 Prognosis / Complications
Locally aggressive behavior, similar to conventional ameloblastoma.
Recurrence risk is high with conservative treatment (simple curettage → up to 60–80%).
No evidence that the granular morphology alone alters prognosis compared with other variants.
Potential for significant local destruction and functional impairment.
Malignant transformation (malignant ameloblastoma / ameloblastic carcinoma) is exceedingly rare.
💊 Treatment
Radical surgical resection with negative margins (>1 cm beyond radiographic limits).
Options: segmental mandibulectomy or maxillectomy, depending on size and location.
Conservative approaches carry high recurrence rates.
Long-term follow-up (10–20 years) is essential due to late recurrences.
Emerging therapies: BRAF inhibitors (± MEK inhibitors) in unresectable or metastatic cases, with early promising results.
📝 Summary
Granular Cell Ameloblastoma (GCA) is a rare variant of ameloblastoma, histologically defined by eosinophilic granular cytoplasm in central tumor cells. Despite its peculiar morphology, its biological behavior is comparable to conventional ameloblastoma: benign but infiltrative, slow-growing, locally destructive, and prone to recurrence after conservative surgery. Management requires radical resection with long-term surveillance.
#️⃣
#MedicalEducation #NotasDePatologia
⚠️ Disclaimer: This text is intended for educational purposes only and does not replace individualized medical or pathological evaluation.
📚 References:
WHO Classification of Tumours Editorial Board. Head and Neck Tumours. 5th ed. Lyon: IARC; 2022.
PathologyOutlines.com. Ameloblastoma. Available at:
pathologyoutlines.com
🖋️ Case and slide coloration courtesy of Dr. Alexandre Carneiro (
@AmcarneiroMD), as part of an academic partnership project.